Lipid Lowering Drugs and Hyperlipidaemia

Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge

1972 • 31,801 citations

Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats

2015 • 5,802 citations

Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart Disease

1971 • 2,055 citations

Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders

1967 • 1,945 citations

ISCHÆMIC HEART-DISEASE IN RELATION TO FASTING VALUES OF PLASMA TRIGLYCERIDES AND CHOLESTEROL

1972 • 770 citations

The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia

1972 • 629 citations

RISKS OF ISCHÆMIC HEART-DISEASE IN FAMILIAL HYPERLIPOPROTEINÆMIC STATES

1969 • 623 citations

Reduction of Blood Cholesterol in Man

1953 • 325 citations

Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia

1972 • 308 citations

Turnover of plasma cholesterol in man

1968 • 295 citations

The significance of alterations in serum lipids in thyroid dysfunction. II. Alterations of the metabolism and turnover of 131-I-low-density lipoproteins in hypothyroidism and thyrotoxicosis.

1965 • 244 citations

Metabolic effects of nicotinic acid and its derivatives

1971 • 213 citations

Trial of Clofibrate in the Treatment of Ischaemic Heart Disease: FIVE-YEAR STUDY BY A GROUP OF PHYSICIANS OF THE NEWCASTLE UPON TYNE REGION

1971 • 210 citations

Lipid and carbohydrate abnormalities in patients with angiographically documented coronary artery disease

1969 • 199 citations

Acute Muscular Syndrome Associated with Administration of Clofibrate

1968 • 193 citations

Dietary and Drug Treatment of Primary Hyperlipoproteinemia

1972 • 185 citations

Effects of hyperlipoproteinemias and their treatment on the peripheral circulation

1970 • 134 citations

COMPLICATIONS DURING CLOFIBRATE TREATMENT OF NEPHROTIC-SYNDROME HYPERLIPOPROTEINÆMIA

1972 • 128 citations

Coronary Disease in Familial Hypercholesterolemia

1967 • 123 citations

Lowering of Serum Cholesterol by the Administration of a Plant Sterol

1954 • 120 citations

Further observations on the effects of atromid and of ethyl chlorophenoxyisobutyrate on serum lipid levels

1963 • 113 citations

The Coronary Drug Project. Initial findings leading to modifications of its research protocol

1970 • 102 citations

Selected Risk Factors in Coronary Disease

1969 • 99 citations

Clofibrate in Coronary Heart Disease

1972 • 96 citations

The Interaction Between Cholestyramine and Drugs

1965 • 87 citations

Effects of colestipol (U-26,597A), a new bile acid sequestrant, on serum lipids in experimental animals and man

1970 • 83 citations

Effect of Neomycin on Serum Cholesterol Level of Man.

1959 • 72 citations

Hypolipidemic Drugs and Lipoprotein Metabolism

1972 • 71 citations

Effect of nicotinic acid on plasma lipids in patients with hyperlipoproteinemia during the first week of treatment

1968 • 68 citations

The metabolism of cholesterol in two hypercholesterolaemic patients treated with cholestyramine.

1969 • 63 citations

Norethindrone Acetate, Postheparin Lipolytic Activity, and Plasma Triglycerides in Familial Types I, III, IV, and V Hyperlipoproteinemia

1971 • 53 citations

Response of Hyperlipoproteinemia to Cholestyramine Resin

1968 • 52 citations

Cholestyramine and nicotinic acid in the treatment of familial hyperbetalipoproteinaemia in the homozygous form

1971 • 52 citations

Some Effects of Atromid on Platelet Economy and Blood Coagulation in Man

1963 • 44 citations

Clofibrate-lnduced acute muscular syndrome

1972 • 42 citations

Reduction of Serum Cholesterol Concentrations by Neomycin, Para-aminosalicylic Acid, and Other Antibacterial Drugs in Man

1961 • 42 citations

Reduction of Serum Cholesterol and Triglyceride Levels by the Combined Administration of Neomycin and Clofibrate

1970 • 34 citations

Ischaemic heart disease: a secondary prevention trial using clofibrate. Report by a research committee of the Scottish Society of Physicians.

1971 • 31 citations

The Effect of Colestipol or Cholestyramine on Serum Cholesterol and Triglycerides in a Long‐Term Controlled Study

1972 • 27 citations

Effect of Orally and Parenterally Administered Neomycin on Plasma Lipids of Human Subjects

1963 • 22 citations

Fine structural changes in the liver in hypercholesteremic patients receiving long-term nicotinic acid therapy.

1967 • 22 citations

Treatment of hypercholesterolaemia with colestipol: a bile sequestrating agent.

1972 • 21 citations

Clofibrate-induced ventricular arrhythmia

1969 • 19 citations

Clofibrate in Ischemic Heart Disease

1972 • 17 citations

XVIII. The clofibrate trials: Another dispute about contratrophic therapy

1972 • 15 citations

The effect of Atromid-S on the fibrinolytic enzyme system

1965 • 15 citations

Dietary lipids and reduction of serum cholesterol levels by neomycin in man.

1967 • 11 citations

The effect of PAS on the cholesterol level in the blood.

1954 • 10 citations

Type IV Hyperlipoproteinemia

1972 • 10 citations

One Year of Sodium Dextrothyroxine Therapy for Hypercholesterolemia

1962 • 8 citations

Primary Hyperlipoproteinaemias in Myocardial Infarction

1972 • 7 citations

Measures to Reduce the Serum Lipid Levels in Coronary Heart Disease

1968 • 7 citations

Treatment of Hypercholesterolemia with Para‐aminosalicylic Acid

1966 • 6 citations

The effect of atromid on serum lipids and coagulation activity

1963 • 5 citations

Cholesterol Reduction in Patients With Arteriosclerosis

1962 • 5 citations

Trial of clofibrate.

1972 • 3 citations

Effects of triparanol on serum low-density lipoproteins and cholesterol.

1962 • 2 citations